Back to search
FDAFDA · Food and drugs·Recall number D-0004-2015

DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02.

Published October 8, 2014 · Recall initiated: September 29, 2014

Summary

FDA records drug Class II recall D-0004-2015, published October 8, 2014 and initiated September 29, 2014. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 11,808 bags; Lot: Lot# P303172; Exp. 12/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.

What to do

Voluntary: Firm initiated · Letter

Get an email if DOPAMINE HYDROCHLORIDE AND DEXTROSE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOPAMINE HYDROCHLORIDE AND DEXTROSE
Manufacturer
Baxter Healthcare Corp.
Distributor
Nationwide and Canada
Lot
Lot# P303172; Exp. 12/14
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DOPamine Hydrochloride and 5% Dextrose INJ, USP, 200 mg per 250 mL, Rx Only, Baxter USA, NDC 0338-1005-02. recalled?

Yes. FDA published recall D-0004-2015 on October 8, 2014. Reported hazard: Lack of Assurance of Sterility: A small cut in the solution bag may have been introduced during the manufacturing process, resulting in a leak of the bag into the overpouch.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOPAMINE HYDROCHLORIDE AND DEXTROSE.